NERVGEN PHARMA CORP. Cash Flows From Used In Financing Activities
NERVGEN PHARMA CORP. (NGEN) reported Cash Flows From Used In Financing Activities of CAD 23.76 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2026-03-31
| Period end | Cash Flows From Used In Financing Activities 12 month |
|---|---|
| 2025-12-31 | 23.76M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 22.70M CAD 40-F · filed 2026-03-31 |